HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Joseph Molnar Selected Research

Joseph Molnar Research Topics

Disease

20	Neoplasms (Cancer) 12/2014 - 03/2002
13	Lymphoma (Lymphomas) 12/2014 - 09/2002
13	Infection 03/2014 - 05/2003
7	Extensively Drug-Resistant Tuberculosis 03/2014 - 05/2009
3	Pulmonary Tuberculosis 03/2014 - 01/2012
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2013 - 07/2010
3	Breast Neoplasms (Breast Cancer) 05/2013 - 01/2009
3	Acquired Immunodeficiency Syndrome (AIDS) 03/2012 - 07/2005
3	Tuberculosis (Tuberculoses) 05/2011 - 03/2003
2	Lung Neoplasms (Lung Cancer) 02/2010 - 01/2007
1	Prostatic Neoplasms (Prostate Cancer) 11/2013
1	Cicatrix (Scar) 04/2009
1	Wounds and Injuries (Trauma) 04/2009
1	Atrioventricular Block 06/2007
1	Necrosis 11/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2005
1	Carcinoma (Carcinomatosis) 05/2005
1	Cross Infection (Nosocomial Infection) 11/2004
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2003
1	Staphylococcal Infections 09/2002

Drug/Important Bio-Agent (IBA)

11	Thioridazine (Mellaril)FDA LinkGeneric 03/2014 - 11/2004
8	phenothiazineIBA 03/2014 - 03/2002
6	Anti-Bacterial Agents (Antibiotics)IBA 03/2014 - 09/2002
6	P-GlycoproteinIBA 11/2013 - 11/2005
3	AntigensIBA 05/2013 - 01/2007
3	Carbon MonoxideIBA 05/2013 - 07/2005
3	PhenothiazinesIBA 07/2005 - 03/2003
2	DiterpenesIBA 12/2014 - 01/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014 - 10/2011
2	butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)IBA 03/2014 - 06/2010
2	Adenosine Triphosphate (ATP)IBA 11/2013 - 11/2009
2	1,3- dimethyl- 1,3- p- fluorophenyl- 1,3- (3- morpholinopropyl)- 1,3- disiloxaneIBA 05/2013 - 03/2008
2	1,3- dimethyl- 1,3- (4- fluorophenyl)- 1,3- (3- butyl- (1- piperazinyl)propyl)- 1,3- disiloxaneIBA 05/2013 - 03/2008
2	Chlorpromazine (Thorazine)FDA Link 12/2011 - 11/2004
2	multidrug resistance-associated protein 1IBA 11/2009 - 01/2009
1	9,10-Dimethyl-1,2-benzanthracene (DMBA)IBA 05/2013
1	disiloxaneIBA 05/2013
1	benz(a)anthracene (benzanthracene)IBA 05/2013
1	Epstein-Barr virus early antigenIBA 05/2013
1	Ethidium (Ethidium Bromide)IBA 03/2012
1	AlkaloidsIBA 06/2011
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2011
1	hinokininIBA 02/2010
1	dihydroguaiaretic acidIBA 02/2010
1	talaumidinIBA 02/2010
1	LignansIBA 02/2010
1	cubebinIBA 02/2010
1	Rhodamine 123IBA 11/2009
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2009
1	AnthracyclinesIBA 07/2009
1	SaponinsIBA 07/2009
1	EnzymesIBA 05/2009
1	1,3- dimethyl- 1,3- bis(4- fluorophenyl)- 1,3- bis(3- (1- (4- butypiperazinyl))propyl)disiloxaneIBA 05/2009
1	FlavonoidsIBA 01/2009
1	Silicon CompoundsIBA 03/2008
1	Diclofenac (SR 38)FDA LinkGeneric 09/2007
1	Tetracycline (Achromycin)FDA LinkGeneric 07/2007
1	Nifedipine (Adalat)FDA LinkGeneric 06/2007
1	Methanol (Carbinol)IBA 01/2007
1	jolkinol BIBA 01/2007
1	lathyraneIBA 01/2007
1	PolyestersIBA 06/2006
1	phenoxazineIBA 01/2006
1	BenzoxazinesIBA 11/2005
1	Heterocyclic CompoundsIBA 11/2005
1	Carotenoids (Carotene)IBA 05/2005
1	AcetoneIBA 05/2005
1	Vancomycin FDA LinkGeneric 11/2004
1	Verapamil (Calan)FDA LinkGeneric 05/2003
1	Methotrimeprazine (Levomepromazine)FDA Link 03/2002
1	Fluphenazine (Prolixin)FDA LinkGeneric 03/2002
1	Triflupromazine FDA Link 03/2002
1	Promazine (Promazine Hydrochloride)FDA Link 03/2002
1	Methotrexate (Mexate)FDA LinkGeneric 03/2002
1	Sulindac (Copal)FDA LinkGeneric 03/2002
1	Promethazine (Promet)FDA LinkGeneric 03/2002
1	Fluorouracil (Carac)FDA LinkGeneric 03/2002
1	propiomazine (Largon)FDA Link 03/2002
1	PhospholipidsIBA 03/2002
1	Trifluoperazine (Stelazine)FDA LinkGeneric 03/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2013 - 05/2003
2	Chemoprevention 05/2013 - 02/2010
1	Heterologous Transplantation (Xenotransplantation) 07/2009
1	Negative-Pressure Wound Therapy 04/2009
1	Length of Stay 04/2009
1	Skin Transplantation (Skin Grafting) 04/2009